Applications Published 16 May 2001
Published: 9-Feb-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Synergistic antimicrobial compsn or peroxyacetic acid and a phosphorus compound
Calgon 1098566*Casein formulations for the delivery of bioactive constituents
Pacific Biolink 1098628*Anti-inflammatory dental care agents
Henkel 1098629*Compsn for enhancing epidermal lipid production
Biomed Research and Technologies 1098630*Pharmaceutical compsn in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy
Laboratoires L Lafon 1098631*Charge reversal of polyion complexes
Mirus Corp 1098632*Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose
Lek Pharmaceutical and Chemical 1098633*Bioenhanced formulations comprising eprosartan in oral solid dosage form
SmithKline Beecham 1098634*Enteric coated pharmaceutical tablet and method of manufacture
Bristol-Myers Squibb 1098635*A wet granulation method for preparing a stable pharmaceutical formulation
Novo Nordisk 1098636*Transdermal patch and topical compsns comprising propylnorapomorphine
Unihart 1098637*Use of a glucose uptake enhancer for reducing post-ischaemic injury of the heart
SmithKline Beecham 1098638*Use of a glucose uptake enhancer for reducing apoptosis
SmithKline Beecham 1098639*Anti-ulcer compsn comprising a polysaccharide containing glucouronic acid
Alpenstock Holdings 1098640*Chemically induced intracellular hyperthemia
Texas Pharmaceuticals 1098641*Methods for treating conditions modulated by lactosylceramide
The Johns Hopkins University 1098642*Treatment regimen for administration of phenylacetylglutamine,
phenylacetylisoglutamine, and/or phenylacetate Burzynski, Stanislaw 1098643*Substituted benzimidazole antiviral agents
Bristol-Myers Squibb 1098644*Compsns comprising phenylaminithiophenacetic acid derivatives for the treatment of acute r adult respiratory disease syndrome (ARDS) and infant respiratory disease syndrome (IRDS)
Byk Gulden Lomberg Chemische Fabrik 1098645*Stabilised carvedilol injection solution
Roche Diagnostics 1098646*Compounds and compsns for treating tissue ischaemia
The Picower Institute for Medical Research 1098647*Pharmaceutical compsns comprising hydroxylansoprazole and uses thereof.
Sepracor 1098648*
Method for stabilising pharmaceutical compsns by special use of an antioxidant
Novartis 1098649*Benzoquinolizidine and benzoindolizidine and therapeutic uses thereof
American Biogenetic Science 1098650*Novel urokinase inhibitors
Wilex Biotechnology 1098651*Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
Schering 1098652*Subcutaneous medroxyprogesterone acetate for contraception
Pharmacia & Upjohn 1098653*Antilipemic compsn comprising a polysaccharide containing a glucoronic acid
Alpenstock Holdings 1098654*Nutritional and therapeutic uses of 3-hydroxylakanoate oligomers
Metabolix 1098655*Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof.
Les Laboratoires Aeterna 1098656*Compsn for treating obesity and asthertic treatment method
Laboratoires Arkopharma 1098657*Engineered proteins for analyte sensing
University of Maryland, Baltimore 1098658*Libraries of polyhydroxamates and their analogues
Metaphore 1098659*Encapsulation of water-soluble peptides
Societe de Conseils de Recherches et d'Applications Scientifiques 1098660*GNRH vaccines for suppressing reproductive behaviour in animals
Metamorphix 1098661*Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions
Warner-Lambert 1098662*Slow release formulations comprising anionic polysaccharide
Alpenstock Holdings 1098663*Conjugates for treating inflammatory disorders and associated tissue damage
Osprey Pharmaceuticals 1098664*Cancer treatment methods using therapeutic conugates that bind to aminophospholipids
Board of Regents of the University of Texas System 1098665*Water-soluble drugs and methods for their production
The United States of America, represented by the Secretary, Department of Health and Human Services, National Institutes of Health, Office of Technology Transfer 1098666* Chelating systems for use in the delivery of compounds to cells
Mirus Corp 1098667*
